Treatment and Prophylaxis of VTE Flashcards
For initial VTE treatment what should patients be given
Rapid-acting anticoagulant
During warfarin initiation what should be overlapped with it, for how long, what parameters should be met
Injectable anticoagulants, 5 days and until the patient’s INR is greater than or equal to 2 for at least 24 hours
T/F: As long at the VTE and PE is uncomplicated patients can be treated outpatient
True
How long should VTE treatment be, when would it be longer
3 months, VTE reccurence and major bleeding
What are the deep veins in the body
Inferior vena cava, Iliac vein, Femoral vein, popliteal vein, anterior tibial vein
What are upper extremity DVT
thrombosis of the brachial, axillary, subclavian, and internal jugular veins
What usually cause the upper extremeity DVTs
Central venous catheter, Implantable cardiac defibrallator, cardiac pacemakers or other foreign implants
What are the three categories that can cause DVTs
Blood stasis, vascular injury, hypercoaguability
What are early methods of prophylaxis for VTE
Active or passive mobilization, Adequate hydration
What are two types of mechanical prophylaxis of VTEs
Graduated compression stockings, Intermittent pneumatic compression devices
Where is the most pressure in graduated compression stockings
At the ankles, decreases going up
How long should intermittent pneumatic compression devices be attached
At least 18 hours
What are the pharmacological choices for VTE prophylaxis is brought for medical illness
Heparin, LMWH, Fondaparinux, Betrixban
What is an appropriate Heparin dose for VTE prophylaxis, LMWH, Fondaparinux
5000 units SC every 8-12 hours, Enoxaparin 40 mg SC daily or 30 mg SC every 12 hours, Dalepartin 2500-5000 units SC daily, 2.5 mg SC daily
Which VTE prophylaxis pharmacologic agent can be taken by mouth, what is the correct dose
Betrixiban 160 mg once then 80 mg daily
According to the Padua Prediction Score what has the highest risk factor (3)
Active cancer, Previous VTE (with exclusion to superficial vein thrombosis), Reduced mobility, already known thrombillic conditions
What score on the Padua constitutes a high risk for VTE, low risk
4 or more, 3 or less
What do the 2018 ASH guidelines recommend for VTE prophylaxis
LMWH over DOACs for acute medically ill patients
T/F: For VTE prophylaxis LMWH should be used alone in inpatient prophylaxis without continuing therapy after discharge
True